SEC reporting owner

DESOUZA ERROL B SEC insider disclosures

Explore DESOUZA ERROL B's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001213895
Issuers
7
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

IDEXX LABORATORIES INC /DE0000874716IDXXNoYes
CATALYST BIOSCIENCES, INC.0001124105TRGT, CBIONoYes
PALATIN TECHNOLOGIES INC0000911216PTNNoYes
Biodel Inc0001322505BIODYesYes
Royalty Pharma plc0001802768RPRXNoYes
Cyclerion Therapeutics, Inc.0001755237CYCNNoYes
Alector, Inc.0001653087ALECNoYes

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

2026-06-182026-06-17ALECA28,700Not reported
2026-06-182026-06-17ALECA9,450Not reported
2025-06-132025-06-11ALECA28,700Not reported
2025-06-132025-06-11ALECA9,450Not reported
2025-05-152025-05-13RPRXA7,614Not reported

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.